Perceptive Advisors LLC Dice Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$19.77 - $42.23 $7.79 Million - $16.6 Million	-394,062 Reduced 57.32%	293,362 $9.15 Million
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $5.46 Million - $8.26 Million	-364,480 Reduced 34.65%	687,424 $13.9 Million
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $6.11 Million - $10.2 Million	-463,457 Reduced 30.58%	1,051,904 $16.3 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $11.8 Million - $20.3 Million	810,476 Added 114.98%	1,515,361 $29 Million
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $15.8 Million - $26.5 Million	704,885 New	704,885 $17.8 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.